Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairment
暂无分享,去创建一个
R. Doughty | A. Richards | E. Espiner | M. Nicholls | T. Yandle | R N Doughty | A M Richards | M G Nicholls | T G Yandle | E A Espiner | P J Hunt | P. Hunt | R. Doughty | P. J. Hunt | A. Richards
[1] S. Anker,et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. , 1997, Circulation.
[2] N. Arakawa,et al. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. , 1996, Journal of the American College of Cardiology.
[3] N. Kennedy,et al. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. , 1996, The American journal of cardiology.
[4] E. Braunwald,et al. Prognostic value of N-terminal proatrial natriuretic factor plasma levels measured within the first 12 hours after myocardial infarction. Thrombolysis in Myocardial Infarction (TIMI) II Investigators. , 1995, Journal of the American College of Cardiology.
[5] A. Richards,et al. The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. , 1995, Biochemical and biophysical research communications.
[6] K. Dickstein,et al. Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function. , 1995, British heart journal.
[7] C. Lang,et al. Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods. , 1994, British heart journal.
[8] K. Kugiyama,et al. Localization and Mechanism of Secretion of B‐Type Natriuretic Peptide in Comparison With Those of A‐Type Natriuretic Peptide in Normal Subjects and Patients With Heart Failure , 1994, Circulation.
[9] O. Vuolteenaho,et al. Plasma N-terminal atrial natriuretic peptide in acute myocardial infarction. , 1994, American heart journal.
[10] S. Snapinn,et al. The plasma concentration of N‐terminal proatrial natriuretic factor anf (1‐98) is related to prognosis in severe heart failure , 1994, Clinical cardiology.
[11] C. Frampton,et al. Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men. , 1994, The American journal of physiology.
[12] A. Richards,et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea , 1994, The Lancet.
[13] K. Nakao,et al. Increased Plasma Levels of Brain Natriuretic Peptide in Patients With Acute Myocardial Infarction , 1993, Circulation.
[14] K. Bailey,et al. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction , 1993, The Lancet.
[15] A. Richards,et al. Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease. , 1993, British heart journal.
[16] A. Richards,et al. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. , 1993, The Journal of clinical endocrinology and metabolism.
[17] C. Frampton,et al. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. , 1993, The Journal of clinical endocrinology and metabolism.
[18] T. Ogihara,et al. Concentrations and molecular forms of human brain natriuretic peptide in plasma. , 1992, Biochemical and biophysical research communications.
[19] K. Hosoda,et al. Augmented secretion of brain natriuretic peptide in acute myocardial infarction. , 1991, Biochemical and biophysical research communications.
[20] T. Kameya,et al. Brain natriuretic peptides in human plasma, spinal cord and cerebrospinal fluid. , 1991, Clinica chimica acta; international journal of clinical chemistry.
[21] H. Imura,et al. Expression of Brain Natriuretic Peptide Gene in Human Heart: Production in the Ventricle , 1991, Hypertension.
[22] N. Minamino,et al. Isolation and identification of human brain natriuretic peptides in cardiac atrium. , 1990, Biochemical and biophysical research communications.
[23] K. Nakao,et al. Isolation and sequence determination of human brain natriuretic peptide in human atrium , 1990, FEBS letters.
[24] R. Woods. Contribution of the kidney to metabolic clearance of atrial natriuretic peptide. , 1988, The American journal of physiology.
[25] M. Cantin,et al. Contribution of blood and systemic circulation to the processing of pro-(atrial natriuretic factor). , 1988, The Biochemical journal.
[26] Naoto Minamino,et al. A new natriuretic peptide in porcine brain , 1988, Nature.
[27] J. Sundsfjord,et al. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. , 1988, The Journal of clinical endocrinology and metabolism.
[28] N. Seidah,et al. NH2-terminal fragment of rat pro-atrial natriuretic factor in the circulation: Identification, radioimmunoassay and half-life , 1988, Peptides.
[29] R M Whitlock,et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.
[30] E. Espiner,et al. HAEMODYNAMIC EFFECTS OF ATRIAL PEPTIDE INFUSION IN HEART FAILURE , 1986, The Lancet.
[31] E. Espiner,et al. Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma. , 1986, The Journal of clinical endocrinology and metabolism.
[32] N Gochman,et al. Incorrect least-squares regression coefficients in method-comparison analysis. , 1979, Clinical chemistry.